Pfizer (PFE)

$28.42 0.12 (0.40%)

10:30 EDT PFE Stock Quote Delayed 30 Minutes

3 Blue-Chip Stocks to Buy on the Dip: May 2024

By Michael Que, InvestorPlace Contributor May 21, 2024

The economy is going to preform well and you need to invest. These are the three blue-chip stocks to buy on the dip before they skyrocket.

3 Blue-Chip Stocks Set to Triple Soon

7 Value Stocks to Buy and Hold for a Decade of Dominance

7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs

Volume:

Previous Close -

Market Cap 159.31B

PE Ratio -568.30

EPS -0.05

Volume (Avg. Vol.) 5.05M

Day's Range $28.41 - $28.67

52-Week Range $25.20 - $40.37

Dividend & Yield $1.64 (5.77%)

PFE Stock Predictions, Articles, and Pfizer News

From InvestorPlace
From the Web

7 Cheap Value Stocks to Buy Now: May 2024

By Ian Bezek, InvestorPlace Contributor May 15, 2024

Worried about a potential market correction? These seven cheap value stocks are bargains today regardless of the broader economic climate.

Biotech Behemoths: 3 Giants Set to Dominate the Health Scene

By Joey Frenette, InvestorPlace Contributor May 14, 2024

The biotech behemoths stand out as compelling and exciting options for investors seeking steady long-term growth.

7 F-Rated Stock Picks to Avoid Like the Plague in May

By Louis Navellier and the InvestorPlace Research Staff May 10, 2024

Consumer stocks, electric vehicle companies and meme stocks top the list of F-rated stock picks to avoid this month.

The 3 Most Undervalued Healthcare Stocks to Buy in May 2024

By Faisal Humayun, InvestorPlace Contributor May 10, 2024

These are the undervalued healthcare stocks to buy as they represent companies with steady growth visibility.

Safeguard Your Future: Top 3 Stocks to Weather Any Market Downturn

By Yiannis Zourmpanos, InvestorPlace Contributor May 9, 2024

Explore three stocks that will resist a market downturn that offer both stability and potential growth during economic fluctuations.

3 Profitable Dividend Stocks to Buy at Near-Lows

By Charles Munyi, InvestorPlace Contributor May 9, 2024

With high yields above 3% and dirt-cheap valuations, these undervalued dividend stocks present a significant margin of safety.

7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025

By Alex Sirois, InvestorPlace Contributor May 9, 2024

The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving.

Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare

By Josh Enomoto, InvestorPlace Contributor May 7, 2024

Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be volatile because…

Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields

By Alex Sirois, InvestorPlace Contributor May 6, 2024

Investing in high-yield dividend stocks under $50 is a low-risk strategy that can result in massive returns in time.

Revive Your Portfolio: 3 Undervalued Stocks Poised for Growth

By Josh Enomoto, InvestorPlace Contributor May 6, 2024

With the sharp rise in the equities space since the beginning of the year, it’s been difficult to find undervalued growth stocks. Still, there are…

3 Ultra-Safe Stocks to Buy So You Can Rest Easy in Any Market

By Alex Sirois, InvestorPlace Contributor May 3, 2024

Defensive stocks are increasingly safe to buy and attractive as volatility rises and indices fall at large, making time tested shares hot.

3 Contrarian Stocks That Could Make You a Fortune (If You Dare)

By Viktor Zarev, InvestorPlace Contributor May 2, 2024

Sometimes the best way to invest your money is in the companies no one is bullish about, just like these three contrarian stocks to buy.

PFE Stock Earnings: Pfizer Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 1, 2024

PFE stock results show that Pfizer beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

3 Pharma Stocks With the Potential to Make You an Overnight Millionaire

By Chandler Capital, InvestorPlace Contributor May 1, 2024

As a result of their enduring significance in healthcare, the pharma industry offers both short and long term opportunities in pharma stocks.

7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 30, 2024

Safe haven stocks offer stability even during market fall in communication, financials, healthcare, energy and consumer staples.

3 Dividend Stocks to Buy on the Dip: April 2024

By Josh Enomoto, InvestorPlace Contributor Apr 29, 2024

At first glance, the concept of dividend stocks to buy on the dip might clash with your instincts. Right now, the combination of robust employment…

7 Dividend Stocks to Buy Now for Steady Returns in Any Market

By Vandita Jadeja Apr 27, 2024

Passive investors pay attention! Invest in the best of the best with these seven dividend stocks for steady returns.

The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 24, 2024

Discover the top dividend stocks for prolonged wealth in 2024 in pharmaceuticals, integrated telecommunications, drug retail, and tobacco.

3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge

By Faisal Humayun, InvestorPlace Contributor Apr 23, 2024

These are the undervalued pharmaceutical stocks to buy as they have a deep clinical pipeline which will driven earnings and cash flow growth.

3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years

By Faisal Humayun, InvestorPlace Contributor Apr 22, 2024

These are the undervalued blue-chip stocks to buy as they represent fundamentally strong ideas poised for accelerated growth.

Pfizer (PFE)

3 Blue-Chip Stocks to Buy on the Dip: May 2024

3 Blue-Chip Stocks Set to Triple Soon

7 Value Stocks to Buy and Hold for a Decade of Dominance

7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Pfizer (PFE)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

PFE Stock Predictions, Articles, and Pfizer News

Subscriber Sign in